TG Therapeutics Inc (TGTX)
Operating profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 20,633 | -192,839 | -344,770 | -273,594 | -169,055 |
| Revenue | US$ in thousands | 221,047 | 2,785 | 6,689 | 152 | 152 |
| Operating profit margin | 9.33% | -6,924.20% | -5,154.28% | -179,996.05% | -111,220.39% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $20,633K ÷ $221,047K
= 9.33%
TG Therapeutics Inc's operating profit margin has shown significant fluctuations over the past five years. In 2023, the operating profit margin improved to 9.33%, indicating that the company generated $0.0933 in operating profit for every dollar of sales. This represents a positive turnaround from the extremely negative margins in the previous years.
In 2022, the operating profit margin was an alarming -6,924.20%, suggesting that the company's operating expenses exceeded its operating income by a substantial amount. Similarly, in 2021 and 2020, the operating profit margins were -5,154.28% and -179,996.05%, respectively, indicating ongoing challenges in controlling costs and generating profits from operations.
The most significant decline was observed in 2019, with an operating profit margin of -111,220.39%, highlighting the company's substantial operating losses relative to its revenue during that year. Overall, TG Therapeutics Inc's operating profit margin has been highly volatile, reflecting the need for strategic management of costs and operational efficiency to improve profitability.
Peer comparison
Dec 31, 2023